Partager Partager sur facebook Partager sur twitter Partager sur google+
-A +A

imprimer la page

« Hallmarks of Cancer : Focus on RNA », an international symposium

« Hallmarks of Cancer : Focus on RNA », an international symposium

October 9th-10th, 2015

From 09.10.2015 to 10.10.2015

Institut Curie

Amphithéâtre Constant Burg
12 rue Lhomond 75005 Paris

Organizers :

Organizers:
Martin DUTERTRE
Stéphan VAGNER
Co-organizers:
Fatima MECHTA-GRIGORIOU
Antonin MORILLON
Honorary organizer:
Geneviève ALMOUZNI

Speakers

Keynote speakers:

Gideon DREYFUSS
Philadelphia, US

Myriam GOROSPE
Baltimore, US

Douglas HANAHAN
Lausanne, CH

Nahum SONENBERG
Montreal, CA

Invited speakers:

Oliver BISCHOF
Paris, FR

Robin FAHRAEUS
Paris, FR

Maite HUARTE
Pamplune, ES

Stefan HUTTELMAIER
Halle, DE

Rotem KARNI
Jerusalem, IL

Anders LUND
Copenhagen, DK

Anne WILLIS
Leicester, UK

Accumulating evidences support the importance of alterations in post-transcriptional steps of gene expression associated with the hallmarks of cancer. The post-transcriptional steps (pre-mRNA splicing and polyadenylation, mRNA stability and translation, modifications of mRNAs) and of post-transcriptional regulators (RNA binding proteins and non-coding RNAs such as microRNAs and long noncoding RNAs) are very diverse and in constant expansion. Hence, it is challenging for scientists involved in cancer research to comprehend this diversity.

11 international experts invited to this symposium will present the recent advances in our understanding of post-transcriptional gene regulation in cancer. This will be complemented by at least 10 selected talks and 60 poster presentations.

The symposium is intended for all people with an interest in both gene regulation and cancer biology. It is also open to those not directly working on RNA biology, including clinicians and medical students or not directly working on cancer, such as basic scientists. It is expected that the small size of the attendance (max 120) will foster stimulating discussions that will lead to collaborations between RNA biologists, cancer researchers and clinicians to the benefit of patients.

Learn more

» Find out more and register on the Symposium website